Skip to main content
TipRanks
Go Ultimate75% OFF

Terminalcare Support Institute, Inc. (7362) AI Stock Analysis

0 Followers
JP:7362

Terminalcare Support Institute, Inc.

(TSE/TYO:7362)

Select Model
Rating:55Neutral
Price Target:JPY 891.00â–²(4.09% Upside)
Action:reiterated
Date:09/11/26

The score is held back primarily by weakening profitability, rising leverage, and sustained negative free cash flow (2023–2025), which collectively elevate financial risk. Technicals are moderately supportive with a mild uptrend versus longer-term averages and neutral momentum, while valuation is a relative positive due to the low P/E and modest dividend yield.

Positive Factors
Consistent Revenue GrowthSustained revenue growth across multiple years indicates continuing demand and business expansion rather than a single-period surge. This provides a durable base for operating leverage and future earnings recovery if the company can stabilize margins and convert sales into cash.
Negative Factors
Margin CompressionFalling margins reduce the earnings produced from each unit of revenue and make future profits more sensitive to operating costs. The sharp 2025 operating-profit decline also lowers confidence that recent revenue growth will translate into durable earnings without a meaningful margin recovery.

Terminalcare Support Institute, Inc. (7362) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%40%JP:7362+6.33%EWJ+15.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 1.30B
Dividend Yield
―
Average Volume (3M)
1,039
Price to Earnings (P/E)
8.1
Beta (1Y)
0.39
Revenue Growth
20.92%
EPS Growth
135.80%
Country
Japan
Employees
511
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Terminalcare Support Institute, Inc. Business Overview & Revenue Model

Company Description

Terminalcare Support Institute Inc., established in 2010 and based in Kyoto, Japan, specializes in offering a comprehensive suite of eldercare services throughout Japan. These services encompass in-home care, preventative health initiatives, direct h...

Terminalcare Support Institute, Inc. Financial Statement Overview

Summary

Despite consistent revenue growth (2020–2025), profitability has weakened materially with notable margin compression and a sharp drop in operating profit in 2025 versus 2024. Leverage has increased significantly (debt-to-equity rising to ~2.5x by 2025), and cash generation is the primary concern: free cash flow has been deeply negative for three consecutive years (2023–2025), indicating sustained cash burn and reduced financial flexibility.

Income Statement

56Neutral

Balance Sheet

44Neutral

Cash Flow

29Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue5.48B4.89B4.71B4.25B4.10B3.40B
Gross Profit767.60M626.27M664.67M646.76M685.84M599.50M
EBITDA348.70M205.09M250.59M196.83M262.62M247.27M
Net Income144.83M81.97M113.77M126.67M157.54M138.03M
Balance Sheet
Total Assets5.96B5.81B4.80B4.09B3.05B2.89B
Cash, Cash Equivalents and Short-Term Investments829.14M1.19B1.13B1.38B1.09B874.72M
Total Debt3.67B3.58B2.81B2.26B1.22B1.43B
Total Liabilities4.48B4.39B3.49B2.90B1.96B1.96B
Stockholders Equity1.48B1.41B1.31B1.19B1.08B927.37M
Cash Flow
Free Cash Flow0-691.25M-780.73M-562.25M317.64M-56.66M
Operating Cash Flow0287.23M304.51M238.18M812.73M462.19M
Investing Cash Flow0-1.01B-1.10B-836.33M-510.68M-523.54M
Financing Cash Flow0771.09M545.64M892.46M-90.11M523.02M

Terminalcare Support Institute, Inc. Technical Analysis

Technical Analysis SentimentPositive
Last Price856.00

Price Trends

50DMA862.04Negative
100DMA860.95Negative
200DMA836.95Positive

Market Momentum

MACD0.11Negative
RSI49.76Neutral
STOCH77.92Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7362, the sentiment is Positive. The current price of 856.00 is above the 20-day moving average (MA) of 852.10, below the 50-day MA of 862.04, and above the 200-day MA of 836.95, indicating a neutral trend. The MACD of 0.11 indicates Negative momentum. The RSI at 49.76 is Neutral, neither overbought nor oversold. The STOCH value of 77.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7362.

Terminalcare Support Institute, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:7362 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9220JP:922070NeutralJPY 3.08B6.39―3.40%5.71%10.34%
JP:2373JP:237357NeutralJPY 5.21B18.02―4.46%4.76%-52.55%
JP:2425JP:242555NeutralJPY 2.50B28.45―3.34%-3.64%-66.52%
JP:7362JP:736255NeutralJPY 1.31B8.14――20.92%135.80%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:7061JP:706149NeutralJPY 3.14B-29.57―6.76%6.75%-119.69%

* Healthcare Sector Average

Performance Comparison

-60%-40%-20%0%20%JP:7362JP:2373JP:2425JP:7061JP:9220Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7362 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7362Terminalcare Support Institute, Inc.856.0035.044.27%
JP:2373Care Twentyone Corporation381.00-47.26-11.04%
JP:2425Care Service Co., Ltd.659.00-103.11-13.53%
JP:7061Japan Hospice Holdings Inc.370.00-903.14-70.94%
JP:9220FB CARE SERVICE CO.,LTD.1265.0079.626.72%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 11, 2026